AMAG Pharmaceuticals CEO and leadership

William Heiden is an experienced pharmaceutical and biotechnology executive who has been chief executive officer of AMAG since May 2012 and served as president from May 2012 through April 2015. Mr. Heiden joined AMAG from GTC Biotherapeutics, Inc. (now rEVO Biologics, Inc.), where he was president and chief executive officer from 2010 to 2012 and chairman of the board of directors from 2007 to 2013. From 2004 to 2008, Mr. Heiden was the president and chief executive officer and a member of the board of directors of Elixir Pharmaceuticals. Prior to that, Mr. Heiden served as president and chief operating officer of Praecis Pharmaceuticals Incorporated (now GlaxoSmithKline plc). Mr. Heiden also held various positions of increasing responsibility at Schering-Plough Corporation (now Merck & Co.), including managing a number of businesses in the United States, Europe and Canada. He currently serves on the board of directors for Atara Biotherapeutics, Inc. Mr. Heiden holds a Bachelor of Arts degree from the University of Florida, a Master of Information Management from the University of Louvain, and a Master of Business Administration from Cornell University’s Johnson Graduate School of Management.

Tony Casciano serves as AMAG’s Chief Operating Officer, bringing over 20 years of commercial experience within the pharmaceutical industry. He joined AMAG in September 2016 and has since held positions of increasing responsibility in the Company. Prior to AMAG, Mr. Casciano served as the Head of Marketing for General Medicines at Sanofi. During his 16 year career at Sanofi, he held multiple commercial leadership roles across a broad range of departments and therapeutic areas. He was also responsible for building and leading top-performing cross-functional commercial teams to achieve aggressive goals for more than a dozen specialty brands. Mr. Casciano holds a Bachelor of Science degree in business administration from Bridgewater State College.

Nicholas Grund is an Exec VP/Chief Commercial Officer at AMAG PHARMACEUTICALS, INC. and Senior Vice President at SANOFI. He has worked as Executive at Genzyme. Nicholas works or has worked as Senior Executive at Bayer Diagnostics. He attended University of Massachusetts Boston and Northeastern University.

Ozgur Kilic is a Chief Financial Officer at AMAG PHARMACEUTICALS, INC..

Elizabeth Bolgiano is a Director:Human Resources at Smith & Nephew and Exec VP/Chief Human Resources Ofcr at AMAG PHARMACEUTICALS, INC. and is based in Greater Boston Area. She has worked as SVP Human Resources at Thermo Fisher Scientific; VP Human Resrouces at Smith & Nephew Orthopaedics; and Senior VP:Human Resources at AMAG PHARMACEUTICALS, INC.. Elizabeth attended Cornell University - S.C. Johnson Graduate School of Management between 1987 and 1989 and Cornell University between 1981 and 1985.